BMC Cancer · 2008 · 107 citations · 26 references
MedicineOncologyPharmacologyCancer PharmacologyOncology PharmacotherapyTumor ProgressionCell MigrationMelanoma PharmacotherapyPharmacodynamics Of Anticancer AgentsTumor Growth KineticsTumor InvasionTumorigenicity AssessmentCancer Cell Proliferation InhibitionCell Migration AnalysisCell Migration DynamicsCell Migration InhibitorsMelanoma ProgressionPeak Plasma Concentration ChangesTumor Cell Proliferation
BACKGROUND: A number of recent studies have suggested that cancer incidence rates may be lower in patients receiving statin treatment for hypercholesterolemia. We examined the effects of statin drugs on in vitro proliferation, migration and invasion of melanoma cells. METHODS: The ability of lovastatin, mevastatin and simvastatin to inhibit the melanoma cell proliferation was examined using cytotoxicity and apoptosis assays. Effects on cell migration and invasion were assessed using transwell invasion and migration chambers. Hypothesis testing was performed using 1-way ANOVA, and Student's t-test. RESULTS: Lovastatin, mevastatin and simvastatin inhibited the growth, cell migration and invasion of HT144, M14 and SK-MEL-28 melanoma cells. The concentrations required to inhibit proliferation of melanoma cells (0.8-2.1 microave previously been achieved in a phase I clinical trial of lovastatin in patients with solid tumours, (45 mg/kg/day resulted in peak plasma concentrations of approximately 3.9 micro CONCLUSION: Our results suggest that statin treatment is unlikely to prevent melanoma development at standard doses. However, higher doses of statins may have a role to play in adjuvant therapy by inhibiting growth and invasion of melanoma cells.
26
Aspirin and the Risk of Colorectal Cancer in Women
Edward L. Giovannucci, Kathleen M. Egan, David J. Hunter et al. · New England Journal of Medicine · 1995 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +12
Statins and the Risk of Colorectal Cancer
Jenny N. Poynter, Stephen B. Gruber, Peter Higgins et al. · New England Journal of Medicine · 2005 · 826 citations
Medicine, Oncology, Pharmacology +12
The Risk of Cancer in Users of Statins
Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts et al. · Journal of Clinical Oncology · 2004 · 526 citations · Full text
Medicine, Oncology, Pharmacology +10